1. http://www.ich.org/LOB/media/MEDIA486.pdf
2. The FDA and the case for Ketek;Ross;New England Journal of Medicine,2007
3. ICH E9 reflections and considerations;Rockhold;Pharmaceutical Statistics,2008
4. Issues on the selection of non-inferiority margin in clinical trials;Hou;Chinese Medical Journal,2009
5. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM202140.pdf